Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2013 16:30 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Present at AACR-NCI-EORTC

DUBLIN, Calif., Oct. 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc., a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced...
October 09, 2013 22:37 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Responds to Further Misleading Claims Made by Sarissa Capital

DUBLIN, Calif., Oct. 9, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX) ("Astex"), a pharmaceutical company dedicated to the discovery and development of novel small molecule...
October 07, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces Expiration of HSR Waiting Period for Pending Transaction

DUBLIN, Calif., Oct. 7, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX) ("Astex"), announced today that the waiting period for U.S. antitrust review under the Hart-Scott-Rodino...
October 02, 2013 19:40 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Issues Open Letter to Stockholders Regarding Otsuka Transaction

Astex Board of Directors Corrects the Record Regarding Recent Mischaracterizations Urges Stockholders to Tender Shares into Otsuka Offer DUBLIN, Calif., Oct. 2, 2013 (GLOBE NEWSWIRE) -- The...
September 30, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress

DUBLIN, Calif., Sept. 30, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
September 06, 2013 18:45 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Withdraws From Upcoming Investor Conferences

DUBLIN, Calif., Sept. 6, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
September 05, 2013 03:48 ET | Source: Astex Pharmaceuticals, Inc.

Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals for $8.50 Per Share in Cash

TOKYO and DUBLIN, Calif., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Otsuka Pharmaceutical Co., Ltd. ("Otsuka") and Astex Pharmaceuticals, Inc. (Nasdaq:ASTX) ("Astex"), announced today that their respective...
September 03, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Present at Investor Conferences in September

DUBLIN, Calif., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
August 28, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study

DUBLIN, Calif., Aug. 28, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX) today announced topline results from the ongoing phase 2 of SGI-110 in patients with AML and MDS. The Phase...
August 01, 2013 08:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results

SGI-110 Clinical Data Presented at EHA for Phase 1 MDS Patients Second Quarter Royalty Revenue Increased 15% to $16.6 Million Royalty Revenue Guidance Revised From $55 Million to $63 Million for...

Next Page keyboard_arrow_right